Hepatoerythropoietic porphyria with coexisting BTD and CNGB1 genetic mutations: a first case report
Open Access
- 18 February 2025
- journal article
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 12 (3) , 005198
Abstract
Introduction: Hepatoerythropoietic porphyria (HEP) is an uncommon autosomal recessive disorder marked by deficiencies in enzymes involved in heme biosynthesis. This results in the build-up of porphyrins and their precursors. Here, we describe a case study of a 17-year-old male who has experienced symptoms of porphyria since early childhood. Case description: The patient exhibited initial symptoms of porphyria, including dark-coloured urine, abdominal pain, constipation and cutaneous lesions. Genetic testing at age 17 confirmed a homozygous mutation in the UROD gene, diagnosing HEP. Additional mutations in the CNGB1 and BTD genes contributed to retinitis pigmentosa and biotinidase deficiency, respectively. The patient also experienced complications such as thumb amputation and finger developmental anomalies. Conclusion: This case underscores the diagnostic challenges and multidisciplinary management required for patients with complex genetic profiles and rare porphyria subtypes such as HEP. Further research is essential to enhance understanding and treatment strategies for such intricate genetic conditions.Keywords
This publication has 7 references indexed in Scilit:
- Overview on Pathophysiology, Diagnosis, and Management of Biotinidase Deficiency in PediatricsArchives Of Pharmacy Practice, 2023
- Laboratory Diagnosis of PorphyriaDiagnostics, 2021
- StatPearls2020
- PorphyriasThe Lancet, 2010
- The diagnosis and management of erythropoietic protoporphyria.2008
- High-dose hydroxychloroquine treatment of porphyria cutane tardaJournal of the American Academy of Dermatology, 1992
- CONTROLLED TRIAL OF HAEM ARGINATE IN ACUTE HEPATIC PORPHYRIAThe Lancet, 1989